ConcR

ConcR is rated 3 out of 5 in the category next-generation oncology drug development. Read and write reviews about ConcR. ConcR is an emerging predictive software platform built to combat cancer. ConcR combines cutting edge machine learning techniques with deep scientific understanding of tumour progression to accurately predict cancers evolution in response to treatment. This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine. ConcR aims to: -Reduce treatment resistance -Cut cost of cancer treatment -Enable proactive treatment adaptation -Save lives